These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 31699325)
1. Prion-like propagation of α-synuclein in neurodegenerative diseases. Tarutani A; Hasegawa M Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325 [TBL] [Abstract][Full Text] [Related]
2. A critical review of the prion hypothesis of human synucleinopathies. Tamgüney G; Korczyn AD Cell Tissue Res; 2018 Jul; 373(1):213-220. PubMed ID: 29116402 [TBL] [Abstract][Full Text] [Related]
3. ɑ-Synuclein strains and the variable pathologies of synucleinopathies. Peelaerts W; Baekelandt V J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014 [TBL] [Abstract][Full Text] [Related]
4. [Prion-like Propagation of Pathological α-Synuclein in Vivo]. Masuda-Suzukake M; Hasegawa M Yakugaku Zasshi; 2019; 139(7):1007-1013. PubMed ID: 31257247 [TBL] [Abstract][Full Text] [Related]
5. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods. Tarutani A; Arai T; Murayama S; Hisanaga SI; Hasegawa M Acta Neuropathol Commun; 2018 Apr; 6(1):29. PubMed ID: 29669601 [TBL] [Abstract][Full Text] [Related]
7. Is Multiple System Atrophy a Prion-like Disorder? Jellinger KA; Wenning GK; Stefanova N Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576255 [TBL] [Abstract][Full Text] [Related]
8. The Effect of Fragmented Pathogenic α-Synuclein Seeds on Prion-like Propagation. Tarutani A; Suzuki G; Shimozawa A; Nonaka T; Akiyama H; Hisanaga S; Hasegawa M J Biol Chem; 2016 Sep; 291(36):18675-88. PubMed ID: 27382062 [TBL] [Abstract][Full Text] [Related]
9. Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein. Rey NL; George S; Brundin P Neuropathol Appl Neurobiol; 2016 Feb; 42(1):51-76. PubMed ID: 26666838 [TBL] [Abstract][Full Text] [Related]
10. Are synucleinopathies prion-like disorders? Angot E; Steiner JA; Hansen C; Li JY; Brundin P Lancet Neurol; 2010 Nov; 9(11):1128-38. PubMed ID: 20846907 [TBL] [Abstract][Full Text] [Related]
11. [Animal models of synucleinopathies: prion-like propagation of alpha-synuclein in wild-type animals]. Masuda-Suzukake M Nihon Yakurigaku Zasshi; 2019; 154(6):301-305. PubMed ID: 31787680 [TBL] [Abstract][Full Text] [Related]
12. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies. Peng C; Gathagan RJ; Lee VM Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258 [TBL] [Abstract][Full Text] [Related]
16. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease. Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061 [TBL] [Abstract][Full Text] [Related]
17. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis]. Yoshida K; Higuchi K; Ikeda S Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474 [TBL] [Abstract][Full Text] [Related]
19. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases. Melki R J Parkinsons Dis; 2015; 5(2):217-27. PubMed ID: 25757830 [TBL] [Abstract][Full Text] [Related]